Funder: Food and Drug Administration (FDA)
Due Dates: Archiving forecast (no current open deadline)
Funding Amounts: Cooperative Agreement; specific award amounts not listed
Summary: Expands an FDA system-dynamic model to incorporate fentanyl, stimulants, and polysubstance use to better understand opioid overdose deaths and evaluate harm reduction strategies.
Key Information: Focus on modeling opioid overdose deaths involving stimulant and polysubstance users; includes harm reduction and mental health factors.